IntelGenx Announces Issuance of New U.S. Patent Covering VersaFilm® Technology
20 oct. 2022 08h30 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Oct. 20, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that the United...
IntelGenx Submits Response to CRL from FDA for RIZAPORT® VersaFilm®
18 oct. 2022 08h00 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Oct. 18, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that it has...
IntelGenx’s Collaboration with atai Life Sciences Culminates in the Initiation of First-in-Human Clinical Study of an Oral Thin Film Psychedelic Drug Candidate
13 oct. 2022 09h21 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Oct. 13, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today provided an update on its collaboration with its strategic...
IntelGenx Announces Enrollment Reaches Halfway Mark in ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease
08 sept. 2022 08h00 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Sept. 08, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that patient enrollment in the ongoing Montelukast...
IntelGenx Reports Second Quarter 2022 Financial Results
11 août 2022 16h05 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Aug. 11, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the second quarter...
IntelGenx to Report Second Quarter 2022 Financial Results on August 11, 2022 – Conference Call to Follow
04 août 2022 08h30 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Aug. 04, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its...
IntelGenx Announces Completion of Share Issuance in Payment of Principal and Interest on Debentures
05 juil. 2022 14h00 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, July 05, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) announces that, as previously disclosed on June 1, 2022...
IntelGenx Announces Intention to Issue Shares in Payment of Principal and Interest on Outstanding Debentures
01 juin 2022 08h30 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, June 01, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) announces that it intends to (i) issue shares of common...
IntelGenx Reports First Quarter 2022 Financial Results
12 mai 2022 16h05 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 12, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the first quarter...
IntelGenx Announces Voting Results on Election of Directors and other items
10 mai 2022 16h05 HE
|
IntelGenx Technologies Corp.
SAINT-LAURENT, Quebec, May 10, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Company”) announces that shareholders voted in favour of all items of business...